Edward J. Ludwig
Chairman of the Board
Mr. Ludwig is lead independent director for the board of directors at Boston Scientific, director of CVS, and chair of the CVS board finance committee.
He formerly served as chairman of the board, president, and CEO of BD (Becton, Dickinson and Company); as director and lead independent director of the Aetna insurance company; as chair of the Finance, Innovation & Technology Committee at Xylem, Inc.; and as chairman of the board at AdvaMed. He also served as a senior auditor with Coopers and Lybrand (now PwC), and as a financial and strategic analyst at Kidde, Inc.
Mr. Ludwig is a founding board member of The Center for Higher Ambition Leadership (CHL), and a past chair of the Health Advisory Board for the Johns Hopkins Bloomberg School of Public Health. He was a member of the board of trustees at the College of the Holy Cross and of the Columbia Business School board of overseers, and a trustee of the Hackensack University Medical Center Network Board of Trustees.
Mr. Ludwig graduated from The College of the Holy Cross with a BA in economics and accounting, and received his MBA in finance from Columbia University.
Mr. Erel is chairman of the board of directors at Cellcom, and a director at Elron, where he previously served as president and chairman of the BOD. He serves as chairman of the board at RDC (the commercialization arm of Rafael Advanced Defense Systems), in a full partnership with Elron. In addition, he serves as a director at Knafaim Holdings, which controls various aviation companies including El-Al; and at Dan Hotels, one of the largest hotel chains in Israel.
Previously, Mr. Erel served as director and chairman of the board of directors at Adama Ltd., currently controlled by Chemchina; as director at Shufersal, Israel’s largest retailer; as president and CEO at Discount Investment Corporation; and as president and CEO of Bezeq. He has also served as chairman of the executive board of Israel’s Manufacturers Association, and as chairman of Israel’s Export & International Cooperation Institute.
Mr. Erel holds a B.Sc in electrical engineering from the Technion, Israel Institute of Technology.
Elron’s CEO since 2009. Extensive experience in managing technology companies, business development, and financial management. Previously VP and Head of the Economic and Business Development Division of Bezeq, Israel’s national landline operator. Holds a BA in Finance and Management and an MA in Finance and Accounting from Tel Aviv University.
Head of Elron’s medical device investments since 2008. Serial entrepreneur, physicist, and well-rounded professional. Broad experience in founding, managing, and successfully exiting Israeli start-up companies. Holds a BSc and an MSc in Physics/Atmospheric Sciences from the Hebrew University and IMT International Campus.
Elron’s CFO since 2010. Extensive experience in accounting, financing and tax. Previously Controller at Elron, and manager in the auditing and technology departments at BDO, a leading Israeli audit firm. Leads Elron’s IT investments and serves as a director at companies within the Elron group. Holds a BA in Economics and Accounting and an MSc in Finance from Tel Aviv University.
Abraham Ludomirski, MD
Dr. Ludomirski is the founder of the Vitalife life sciences fund. He is an internationally renowned physician with over 20 years of experience in life sciences, and expertise in medical devices, health homecare, and biomaterials. He founded the SafeKeeping company for remote monitoring of high risk pregnancies and has served as a consultant to several Israeli and American VC funds and large medtech companies, including GE Medical, ATL-Philips, Medison, Matria Healthcare, and QED Technologies.
Dr. Ludomirski has instructed and led several startups through financing, strategic partnerships, joint ventures, and successful regulatory clearances. He currently serves as director or chairman at BioControl Medical, Deep Breeze, DIR Technologies, EndoSpan, MST, Recro Pharma, and Sensible Medical Innovations. Previously, he served as chairman of Sightline Technologies (sold to Stryker) and MediGuide (sold to St. Jude).
Dr. Ludomirski earned his MD at the Sackler Tel Aviv University Medical School, specializing in OB-GYN. He completed his fellowship in maternal fetal medicine at the University of Pennsylvania, where he became one of the founders of the fetal surgery program and established an internationally known fetal blood-sampling registry. He served as director of the maternal fetal medicine division and as a professor of OB-GYN at Temple University Medical School. Dr. Ludomirski has published numerous articles in peer-reviewed journals and has lectured around the world.
Mr. Lapidot serves as CEO of IDB Development and as acting CEO of Discount Investments. He is as a member of the board of directors at IDB, DIC, Shufersal, and Cellcom, chairman of the BOD at Modi’in Energy Management Ltd., substitute director at Elron Electronic Industries, committee member at the IDB Fund, and member of the BOD of additional private companies owned by DIC and IDB.
He previously served as a member of the board of Adama Agricultural Solutions, as CEO and member of the board at CLADD S.A., and as a member of the board at Australtex S.A.
Mr. Lapidot holds a degree in rabbinical studies, economic science, and Jewish philosophy from Universidad Católica Argentina in Buenos Aires.
Director, Co-Founder, President and CEO
Mr. Gurfinkel brings to the company accumulated management and technical experience in leading high-tech companies. Mr. Gurfinkel holds a Bachelor and M.Sc. in Electrical Engineering from Ben-Gurion University of the Negev, Beer-Sheba, Israel; and an EMBA from the Hebrew University of Jerusalem.